Medicare AdvantageCoverageMedium impact
MA00.005an, Experimental/Investigational Services
Independence Blue Cross·Medical Policy
Effective date
Jan 1, 2025
We identified it
Jun 19, 2026
Summary
Policy MA00.005an regarding Experimental/Investigational Services coverage and reimbursement has been updated effective January 1, 2025. This recent policy change (posted February 10, 2025) affects how Medicare Advantage plans classify and reimburse experimental or investigational procedures and services. Billing teams must review updated coverage criteria and ensure claims are coded and submitted according to the new guidance.
Action Required
By March 15, 2025: Billing team must obtain and review the complete MA00.005an policy text from the provided URL to identify specific experimental/investigational services affected. Coordinate with clinical providers to understand which procedures now require prior authorization or have changed coverage status. Update billing software and encounter forms to reflect any new coding requirements or coverage restrictions for experimental services. Monitor claim denials related to experimental procedures and escalate to compliance if patterns emerge. Document all policy changes in internal billing procedures manual.